鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析

吴建均; 鲍颖菲; 赵扬; 蔡和平; 杨樟卫; 周佳; 王学彬; 陈翠敏; 吴建均; 鲍颖菲; 赵扬; 蔡和平; 杨樟卫; 周佳; 王学彬; 陈翠敏

doi:10.3969/j.issn.1006-0111.2015.05.024

[1]

Jiang M, Zhang Z, Zhao S. Epidemiological characteristics and drug resistance analysis of multidrug-resistant Acinetobacter baumannii in a China hospital at a certain time[J]. Pol J Microbiol, 2014,63(3):275-281.

[2]

Muraki Y,Kitamura M,Maeda Y,et al.Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010 [J].Infection,2013,41(2):415-423.

[3]

马序竹,吕媛.鲍曼不动杆菌对主要抗菌药物耐药机制[J].中国临床药理学杂志,2009,25(1):90-94.

[4]

应舂妹,翁文浩.鲍曼不动杆菌多重耐药机制研究进展[J].检验医学,2007,22(2):208-212.

[5]

王艳丽,黄茂,梅亚宁,等.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270.

[6]

Bergogne BE,Joly-Guillou ML,Towner KJ.Acinetobacter microbiology,epidemiology,infections,management [M].New York:CRC Press,1996:101-115.

[7]

Bou G,Cervero G,Dominguez MA,et al.Characterization of a nosocomial outbreak caused by a multiresisrant Acinetobacter baumannii strain with a carbapenemhydrolyzing enzyme:high-level carbapenem resistance in A.baumannii is not due solely to the presence of β-lactamases[J].J Clin Microbiol,2000,38:3299-3305.